Skip to main content
Home
FDA
  • START A TRIAL
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Webinars
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Not Yet A Subscriber?
Click here to register for a free trial

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Mar 7, 2023
    Permanent Injunctions Entered Against Three Distributors Over Marketing Claims
  • Feb 28, 2023
    FDA Debars Former Chief Executive and Former Medical Director Over Marketing Claims
  • Feb 22, 2023
    CDRH Issues Warning Letter Over Off-label Promotion
  • Feb 10, 2023
    Studies Reveal That Most DTC Advertising Is for Drugs with Low Added Clinical Benefit
  • Feb 7, 2023
    PMCPA Issues UK’s First Guidance on Social Media
  • Jan 29, 2023
    NAD Finds Drug Claim Supported in Physician-Directed Messaging But Not in Consumer-Directed Ads
  • Jan 25, 2023
    DePuy Synthes To Pay $9.75 Million To Resolve Allegations of Providing Free Devices to Surgeon
  • Jan 24, 2023
    Physicians’ Group Files OPDP Complaint Over 60 Minutes’ Wegovy Segment
  • Jan 13, 2023
    Omnibus Spending Act Codifies FDA Guidance on Communications with Payors
  • Jan 6, 2023
    Arizona Sues Drug Maker Over Potency Statements
  • More

Good Clinical Practice

  • Jun 13, 2023
    FDA Debars Two Former Trial Coordinators
  • Jun 11, 2023
    FDA Issues Warning Letters to Two Clinical Investigators
  • Jun 5, 2023
    Number of BIMO Inspection Observations Dips Slightly in FY 2022
  • May 28, 2023
    Draft ICH GCP Guideline Looks To Aid Use of New Technology in Clinical Trials
  • May 14, 2023
    FDA Opens Dialogue on Possible Benefits, Harms From Use of AI/ML in Drug Development
  • May 6, 2023
    FDA: Decentralized Trials Still Need Central Location for Records
  • Apr 25, 2023
    FDA Debars Former Trial Site Co-Owner
  • Apr 18, 2023
    FDA Now Recommends Risk-Based Monitoring for Clinical Trials
  • Apr 13, 2023
    FDA, OHRP Tell Sponsors How To Navigate Agency Pediatric Research Referrals
  • Mar 31, 2023
    Clinical Investigators Receive Warning Letters Over Lack of IND and Not Following Protocol
  • More

U.S. Food Labeling

  • Sep 29,2022
    Administration Proposes Labeling Changes as Part of National Food Strategy
  • Sep 16,2022
    District Court Upholds Majority of NBFDS Regulations But Rejects Text Message Disclosure Option
  • Sep 15,2022
    Groups Want FDA To Beef Up Front-of-Package Nutrition Labeling Requirements
  • Sep 1,2022
    Studies Look at Market Effect of Mandated GMO Labeling Under Vermont Law
  • Aug 18,2022
    FDA Finalizes Guidance on Supplements Containing NAC
  • Jul 30,2022
    AMS Proposes Two Additions to List of Bioengineered Foods
  • Jul 21,2022
    Petitioners Ask FSIS To Stop Approving Labels With Animal Raising Claims, Grant Flexibility for Beef Stroganoff Product
  • Jul 7,2022
    National Chicken Council Wants FDA, FSIS To Address Allegedly Misleading Plant-based Product Marketing Claims
  • Jun 23,2022
    Members of Congress Want Changes to Plant-Based Milk Guidance Before Release
  • Jun 9,2022
    Bill Would Create FDA-Managed Dietary Supplement List
  • More

FDA Regulation & Enforcement

  • Jan 28, 2025
    Congress Reintroduces Bills To Require Price Disclosures in DTC Ads
  • Jan 24, 2025
    FDA Provides Draft Guidance on Labeling Plant-Based Alternative Foods
  • Jan 22, 2025
    Providing Free Drug That Has Only Limited Coverage Will Not Trigger Sanctions, HHS OIG Says
  • Jan 17, 2025
    FDA Proposes Front-of-Package Label for Food Products
  • Jan 15, 2025
    OIG: Patient Assistance for Autologous T-Cell Treatment Would Not Trigger Administrative Sanctions
  • Jan 15, 2025
    Former McKinsey Partner Pleads Guilty to Obstruction Charge Tied to Firm’s Advice to Purdue Pharma
  • Jan 10, 2025
    FDA Issues ‘Safe Harbor’ Guidance on Providing SIUU Info to Health Care Providers
  • Jan 10, 2025
    FDA Allergen Labeling Guidance Expands Interpretation of 'Milk,' 'Eggs'
  • Jan 8, 2025
    Athira To Pay Over $4 Million To Resolve False Claims Allegations Stemming From Research Misconduct
  • Jan 5, 2025
    FDA Sets Jan. 1, 2028, as Next Uniform Compliance Date for New Labeling Regs
  • More

Medical Devices

  • Feb 15, 2024
    AdvaMed Opposes Proposed FTC ‘Right To Repair’ Rulemaking, Citing Safety and Performance Risks
  • Feb 7, 2024
    FDA Announces Initiative To Reclassify High-Risk IVDs To Make Them Eligible for 510(k) Clearance
  • Feb 1, 2024
    Former Device Firm Employee Who Forged FDA 510(k) Clearance Letters Will Serve 12 Months in Prison
  • Jan 31, 2024
    FDA Issues Quality Management System Regulation Final Rule, Incorporating ISO 13485 Standards
  • Jan 25, 2024
    Senators Ask GAO To Review FDA Oversight of Recalls in Wake of Philips Respironics Device Problems
  • Jan 18, 2024
    FDA Offers Guidelines for Third-Party EUA Review, Revises Third-Party 510(k) Review Guidance
  • Jan 10, 2024
    FDA Encourages Use of Vaporized Hydrogen Peroxide as Alternative to EtO for Device Sterilization
  • Jan 4, 2024
    OIG: Subsidies for Study Participants Covered by Medicare Would Not Pose Undue Risk of Fraud, Abuse
  • Jan 3, 2024
    CDRH Begins Issuing Export Documents in Electronic Form, Offers Online Authenticity Verification
  • Dec 21, 2023
    Draft Guidance Describes How FDA Evaluates RWD To Determine Usefulness of RWE in Its Decision-Making
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports
  • Webinars
  •  

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • Headquarters
  • 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.